- Citations, last 5 years
- 160
- Works, last 5 years
- 16
- h-index
- 22
- Scientists listed
- 0
- Grants since 2016
- 4
Grants received
2023–2025 · research · R43
Perform non-GLP and GLP TOX/TK studies, and file a novel drug IND with the FDA for advanced pancreatic cancer patient clinical trials
Fengzhi Li · Canget BioTekpharma (United States) · funded by National Institutes of Health
2018–2020 · research · R43
A novel small molecule FL7N-1 for treating pediatric cancer retinoblastoma
Fengzhi Li · Canget BioTekpharma (United States) · funded by National Institutes of Health
2018–2019 · research · R44
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer
Fengzhi Li · Canget BioTekpharma (United States) · funded by National Institutes of Health
2014–2020 · research · R44
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer
Fengzhi Li · Canget BioTekpharma (United States) · funded by National Institutes of Health